0001600135-14-000005.txt : 20141022
0001600135-14-000005.hdr.sgml : 20141022
20141022150348
ACCESSION NUMBER: 0001600135-14-000005
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140930
FILED AS OF DATE: 20141022
DATE AS OF CHANGE: 20141022
EFFECTIVENESS DATE: 20141022
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Third Rock Ventures, LLC
CENTRAL INDEX KEY: 0001600135
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16025
FILM NUMBER: 141167587
BUSINESS ADDRESS:
STREET 1: 29 NEWBURY STREET
STREET 2: 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: 29 NEWBURY STREET
STREET 2: 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001600135
XXXXXXXX
09-30-2014
09-30-2014
Third Rock Ventures, LLC
29 NEWBURY STREET
3RD FLOOR
BOSTON
MA
02116
13F HOLDINGS REPORT
028-16025
N
Kevin Gillis
Chief Financial Officer
617-585-2000
/s/ Kevin Gillis
Boston
MA
10-22-2014
0
6
857334
false
INFORMATION TABLE
2
trv.xml
Agios Pharmaceuticals, Inc.
COM
00847X104
188350
3070090
SH
DFND
3070090
0
0
bluebird bio, Inc.
COM
09609G100
43596
1215054
SH
DFND
1215054
0
0
Eleven Biotherapeutics, Inc.
COM
286221106
53935
4841591
SH
DFND
4841591
0
0
Foundation Medicine, Inc.
COM
350465100
93420
4927234
SH
DFND
4927234
0
0
Sage Therapeutics, Inc.
COM
78667J108
367952
11681008
SH
DFND
11681008
0
0
Zafgen Inc.
COM
98885E103
110080
5602045
SH
DFND
5602045
0
0